20 May 2013
Keywords: structure, hep, protease, solved, marks, biotechnology, companies
Article | 28 October 1996
As biotechnology companies with a key interest in virology, Agouron and
Vertex have a lot in common. But even more ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 October 1996
17 May 2013
© 2013 thepharmaletter.com